Cargando…
Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses
With severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emergent human virus since December 2019, the world population is susceptible to coronavirus disease 2019 (COVID-19). SARS-CoV-2 has higher transmissibility than the previous coronaviruses, associated by the ribonucleic acid (RN...
Autores principales: | Lim, H.T., Kok, B.H., Lim, C.P., Abdul Majeed, A.B., Leow, C.Y., Leow, C.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482557/ https://www.ncbi.nlm.nih.gov/pubmed/36158162 http://dx.doi.org/10.1016/j.bea.2022.100054 |
Ejemplares similares
-
Corrigendum to ’Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses’: Biomedical Engineering Advances 4 (2022) 100054
por: Lim, H.T., et al.
Publicado: (2023) -
Structural basis for broad coronavirus neutralization
por: Sauer, Maximilian M., et al.
Publicado: (2021) -
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
por: Chen, Yanjia, et al.
Publicado: (2022) -
Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody
por: Cheong, Wei Shien, et al.
Publicado: (2020) -
Dengue virus infection – a review of pathogenesis, vaccines, diagnosis and therapy
por: Kok, Boon Hui, et al.
Publicado: (2022)